IDEFIX Multiorgan toxicity and efficacy test platform

Project Information

IDEFIX

Grant agreement ID: 101099775

DOI 10.3030/101099775

Project closed

EC signature date 26 October 2022

Start date 1 November 2022

End date 31 August 2024

Funded under

• The European Innovation Council (EIC)

Total cost € 2 496 073,25

EU contribution € 2 496 073,00

Coordinated by

CHERRY BIOTECH
France

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Demonstrators, pilots, prototypes (2)

MPS disposable reusable moulds

Reusable Moulds for MPS disposable injection mouldingspecific for each selected biological model

2nd batch of IDEFIX Platform

Provide 15 modular platforms for pre-commercialisation

Websites, patent fillings, videos etc. (1)

Project webpage publication

Publication on Cherrys website of the Project webpage

Publications

Conference proceedings (2)

Towards the development of an in vitro human vascularized immunocompetent metastatic melanoma-on-chip model

Author(s): Elisabetta Michielon; Tanja de GruIijl; Taco Waaijman; Matteo Boninsegna; Divyasree Prabhakaran; Hadhemi Mejri; Antoni Homs Corbera; Pierre Gaudriault; Susan Gibbs; Dario Fassini
Published in: Cancer Research, Issue 83, 2023, ISSN 1538-7445
Publisher: AACR

A high throughput vascularized immunocompetent tumoroids model in a standard multiwell plate for precision oncology

Author(s): Stijn Robben; Anais Peyron; Ana Rita Ribeiro; Divyasree Prabhakaran; Antoni Homs Corbera; Pierre Gaudriault; Patricia Davidson; Dario Fassini
Published in: Cancer Research, Issue 83, 2023, ISSN 1538-7445
Publisher: AACR

Intellectual Property Rights

Trademark (1)

Organ on Well

Application/Publication number: Organ on Well trademark 1
Date: 2023-06-13
Applicant(s): CHERRY BIOTECH